Rett Syndrome (RTT) is an Autism Spectrum Disorder (ASD) of known monogenic cause. It represents one of the leading causes of intellectual and developmental disabilities in females. RTT is caused by mutations or duplications of the gene encoding MeCP2, a methyl DNA binding protein thought to modulate global gene expression. Mice with loss of function of MeCP2 (knock-out) have a range of physiological and neurological abnormalities that mimic the human syndrome. Despite the fact that most RTT-causing mutations are clustered at the methyl-CpG binding domain of MeCP2, it is not known if disruption of methyl-CpG recognition alone is sufficient to cause RTT. Moreover, the mechanisms by which MeCP2 dysfunction leads to RTT remain poorly understood. Recently, we have developed a knock-in mouse carrying a missense mutation of MeCP2 at Threonine 158 (T158A). T158 is located at the methyl-CpG binding domain of MeCP2 and is the most common missense mutation associated with human patients. Preliminary studies suggest T158A mutation impairs the ability of MeCP2 to recognize methylated DNA. In addition, T158A knock-in mice appear to show similar symptoms to MeCP2 knock-out mice. Thus, within the scope of this New Program Development Award, we plan to focus on the following specific aims: 1) Phenotypic characterication of the MeCP2 T158A knock-in mice in comparison to MeCP2 knock-out mice. 2) Dissection of the molecular and cellular functions of MeCP2 with MeCP2 T158A knock-in mice. In the long run, we hope to not only gain insights into the pathogenic mechanisms of RTT, but also uncover therapies and cures for ASD.

Public Health Relevance

Current treatment options for ASD are limited, and clinical progress has been slow due to a poor understanding of ASD etiology. At present, Rett Syndrome is the only ASD with a known cause. Thus, understanding the pathogenic basis of RTT will not only shed light on other ASD, but also improve methods for the diagnosis and treatment of other intellectual and developmental disabilities.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Center Core Grants (P30)
Project #
5P30HD026979-25
Application #
8723679
Study Section
Special Emphasis Panel (ZHD1-MRG-C)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
25
Fiscal Year
2014
Total Cost
$66,830
Indirect Cost
$43,866
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Yerys, Benjamin E; Herrington, John D; Satterthwaite, Theodore D et al. (2017) Globally weaker and topologically different: resting-state connectivity in youth with autism. Mol Autism 8:39
Chapman, Kimberly A; Ostrovsky, Julian; Rao, Meera et al. (2017) Propionyl-CoA carboxylase pcca-1 and pccb-1 gene deletions in Caenorhabditis elegans globally impair mitochondrial energy metabolism. J Inherit Metab Dis :
Monnerie, Hubert; Romer, Micah; Jensen, Brigid K et al. (2017) Reduced sterol regulatory element-binding protein (SREBP) processing through site-1 protease (S1P) inhibition alters oligodendrocyte differentiation in vitro. J Neurochem 140:53-67
Yerys, Benjamin E; Nissley-Tsiopinis, Jenelle; de Marchena, Ashley et al. (2017) Evaluation of the ADHD Rating Scale in Youth with Autism. J Autism Dev Disord 47:90-100
Glauser, Tracy A; Holland, Katherine; O'Brien, Valerie P et al. (2017) Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. Ann Neurol 81:444-453
Hanamura, Kenji; Washburn, Halley R; Sheffler-Collins, Sean I et al. (2017) Extracellular phosphorylation of a receptor tyrosine kinase controls synaptic localization of NMDA receptors and regulates pathological pain. PLoS Biol 15:e2002457
Chen, Yong; Bang, Sookhee; McMullen, Mary F et al. (2017) Neuronal Activity-Induced Sterol Regulatory Element Binding Protein-1 (SREBP1) is Disrupted in Dysbindin-Null Mice-Potential Link to Cognitive Impairment in Schizophrenia. Mol Neurobiol 54:1699-1709
White, Rachel S; Bhattacharya, Anup K; Chen, Yong et al. (2016) Lysosomal iron modulates NMDA receptor-mediated excitation via small GTPase, Dexras1. Mol Brain 9:38
Herrington, John D; Miller, Judith S; Pandey, Juhi et al. (2016) Anxiety and social deficits have distinct relationships with amygdala function in autism spectrum disorder. Soc Cogn Affect Neurosci 11:907-14
Mlynarski, Elisabeth E; Xie, Michael; Taylor, Deanne et al. (2016) Rare copy number variants and congenital heart defects in the 22q11.2 deletion syndrome. Hum Genet 135:273-85

Showing the most recent 10 out of 311 publications